A detailed history of Advisor Group Holdings, Inc. transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,190 shares of LEXX stock, worth $6,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,190
Previous 450 386.67%
Holding current value
$6,088
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.29 - $6.25 $2,244 - $10,875
1,740 Added 386.67%
2,190 $7,000
Q4 2023

Feb 12, 2024

SELL
$0.92 - $1.69 $184 - $338
-200 Reduced 30.77%
450 $0
Q3 2023

Nov 13, 2023

SELL
$0.72 - $1.11 $1,002 - $1,546
-1,393 Reduced 68.18%
650 $0
Q1 2022

May 04, 2022

BUY
N/A
1,674 Added 453.66%
2,043 $7,000
Q3 2021

Nov 05, 2021

BUY
N/A
200 Added 118.34%
369 $2,000
Q2 2021

Aug 02, 2021

BUY
N/A
3 Added 1.81%
169 $1,000
Q1 2021

May 13, 2021

BUY
N/A
166 New
166 $1,000

Others Institutions Holding LEXX

About Lexaria Bioscience Corp.


  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $16.5M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.